Carnitine (L-Carnitine)Amino Acid

• Alzheimer's disease and dementiaPossibly helps

  A 2003 meta-analysis of 21 trials found benefits from 1.5–3.0 g/day of acetyl-L-carnitine [1].
  
  A 2003 Cochrane Review covering overlapping trials found symptom improvement at 12 and 24 weeks but not at 52, and concluded routine clinical use was not justified [1].
  
  More recent trials have come out less positive than the earlier ones [1]. ^[1]

• Heart attack and heart failurePossibly helps

  A meta-analysis of 13 trials in acute myocardial infarction patients (2.7–6 g/day) found lower all-cause mortality, fewer ventricular arrhythmias and less new-onset angina [1].
  
  It found no effect on heart failure or reinfarction risk [1].
  
  A separate meta-analysis of 17 chronic heart failure trials (1–6 g/day) found ejection fraction improved by 4.14%, plus better stroke volume and cardiac output — with no mortality effect [1]. ^[1]

• Signals pointing the other way on heart riskPossibly helps

  ⚠ Not all the cardiovascular evidence points one direction, and we are not averaging it away.
  
  A 2022 trial of 1 g twice daily for 6 months in metabolic syndrome raised total and LDL cholesterol versus placebo, with 9.3% greater carotid plaque stenosis in a male subgroup [1].
  
  A 2013 study linked plasma L-carnitine to coronary and peripheral artery disease risk, specifically in people with high levels of the gut-microbiota metabolite TMAO [1].
  
  NIH's own read is that the implications are not well understood and need more research [1]. ^[1]

• Insulin resistance and type 2 diabetesLikely helps

  A 2023 meta-analysis of 41 RCTs (2,900 adults) tested L-carnitine at 0.25–4 g/day for 2 to 52 weeks [1].
  
  Fasting blood glucose, insulin resistance and HbA1c all came down; serum insulin itself did not move [1]. This is the most consistent efficacy signal carnitine has. ^[1]

• Male fertilityPossibly helps

  A meta-analysis of 3 trials (201 infertile men) found sperm motility up 7.84% and morphology up 4.91%, with no change in sperm concentration [1].
  
  A larger 2022 Cochrane Review of 6 trials (1,089 men) found motility and concentration improved at some timepoints [1]. It found no effect on live birth or pregnancy rates — the outcomes that actually matter here. ^[1]

• PCOSPossibly helps

  Two randomized trials of 3 g/day L-carnitine in women with PCOS reported better ovulation and pregnancy rates, one alongside clomiphene and one on its own [1].
  
  Miscarriage-rate effects were inconsistent between the two trials [1]. ^[1]

• Knee osteoarthritisPossibly helps

  ⚠ Two trials, opposite answers.
  
  One trial of 250 mg three times daily reduced inflammatory markers and pain in women with knee osteoarthritis [1].
  
  Another, at 1 g/day, found no benefit for pain, stiffness or function [1]. ^[1]

• Athletic performancePossibly helps

  Systematic reviews spanning 1–4 g/day land inconsistently, sometimes within the same review [1].
  
  Some trials show lower lactate, higher VO2max and faster recovery; others show nothing at all [1].
  
  No reviewed trial found a benefit for moderate-intensity exercise specifically [1]. ^[1]

• Weight lossLikely helps

  A 2016 meta-analysis of 9 trials (911 adults, 1.8–4 g/day for 30 to 360 days) found carnitine users lost 1.33 kg more than placebo users [1].
  
  The effect held regardless of dose or duration, which is what makes it consistent rather than large [1]. ^[1]

• Peripheral artery disease leg painPossibly helps

  Propionyl-L-carnitine has been studied for intermittent claudication, the leg pain that comes from poor circulation [1].
  
  Across a systematic review of 3 randomized trials (456 participants), only 1 of 3 showed a benefit for peak walking time [1]. ^[1]

• Primary carnitine deficiency — a rare inherited defect in the OCTN2 cellular carnitine transporter (the SLC22A5 gene), usually appearing in infancy or early childhood [1][7]
• In infants it can cause epilepsy and encephalopathy
• In adolescents and young adults: seizures, irregular heartbeat and breathing problems
• In older individuals: myopathy, rhabdomyolysis, cardiomyopathy or sudden death
• Even carriers without symptoms carry a raised lifelong risk of heart failure, liver disorders and coma
• Secondary carnitine deficiency — driven by something else, such as chronic renal failure, or long-term use of pivalate-containing medications
• Its signs: hyperammonemic encephalopathy (malaise, seizures, reduced consciousness from high blood ammonia), hypoglycemia, low blood ketones, dicarboxylic aciduria and raised uric acid
• Also muscle weakness, myoglobin in the urine, cardiomyopathy and sudden death
• Highest-risk groups: premature infants, plus people with end-stage renal disease or on hemodialysis, where low carnitine can contribute to anemia, muscle weakness, fatigue and altered blood lipids
• Both forms are corrected with high-dose supplemental carnitine, 20–200 mg/kg/day, under medical supervision [1]
• Neither is something a healthy adult develops from diet — the liver and kidneys make enough [1]^[1]

• L-carnitineGeneral supplementation, and the base of the prescription drug levocarnitine.

  Elemental content

  The unacetylated form the body produces itself

  Absorption

  Supplemental oral bioavailability is 14–18%, against 63–75% for carnitine from food

  Best for

  General supplementation, and the base of the prescription drug levocarnitine. It reached the highest peak plasma level and longest half-life of the three forms after a 2.0 g dose in 12 volunteers [3]

• Acetyl-L-carnitine (ALCAR)The form researchers use in dementia and cognitive-decline studies, specifically for that reason

  Elemental content

  Acetylated derivative of L-carnitine

  Absorption

  Better absorbed from the small intestine and crosses the blood-brain barrier more efficiently than plain L-carnitine

  Best for

  The form researchers use in dementia and cognitive-decline studies, specifically for that reason [1]

• Propionyl-L-carnitine (PLC)Studied mainly for intermittent claudication, where 1 of 3 randomized trials showed a peak-walking-time benefit

  Elemental content

  Acyl derivative of L-carnitine

  Absorption

  Lower peak plasma concentration and shorter half-life than plain L-carnitine

  Best for

  Studied mainly for intermittent claudication, where 1 of 3 randomized trials showed a peak-walking-time benefit [1]

• Tablet vs chewable vs oral solutionWhichever one you will actually take — the format does not change absorption

  Elemental content

  330 mg tablet, 1 g chewable tablet, and an enteral solution were compared head to head

  Absorption

  All three came out bioequivalent in 15 volunteers, at roughly 18% absolute bioavailability (14–16% baseline-corrected)

  Best for

  Whichever one you will actually take — the format does not change absorption [4]

• Doses at 3 g/day and up

  Nausea, vomiting, abdominal cramps, diarrhea and a fishy body odor are the documented effects at 3 g/day or higher [1][2].
  
  Milder gastrointestinal upset gets reported at lower doses too [2]. ^[1]

• Uremia and seizure disorders

  Carnitine can trigger muscle weakness in people with uremia [1].
  
  In people with seizure disorders it can trigger seizures [1]. Both are specific clinical populations, not general warnings. ^[1]

• Thyroid

  Carnitine acts as a peripheral antagonist of thyroid hormone, blocking T3 and T4 entry into cell nuclei [9].
  
  A randomized double-blind placebo-controlled trial used 2 or 4 g/day against symptoms of iatrogenic hyperthyroidism in women on suppressive levothyroxine [9].
  
  ⚠ The widespread online warning to avoid carnitine with an underactive thyroid does not trace to any trial in hypothyroid patients [9].
  
  It extrapolates from the antagonist mechanism. Worth raising with a prescriber, but it is not a documented harm. ^[9]

• Anticonvulsants

  Valproic acid, phenobarbital, phenytoin and carbamazepine all lower blood carnitine levels [1].
  
  Valproic acid in particular can cause hepatotoxicity and raised ammonia, and intravenous L-carnitine is given for valproic acid toxicity [1]. ^[1]

• Pivalate-conjugated antibiotics

  Chronic use of pivalate-conjugated antibiotics such as pivampicillin depletes carnitine [1].
  
  No case of resulting illness has been documented, so this is a measurable depletion without a known clinical consequence [1]. ^[1]

• Warfarin and acenocoumarol

  A major drug-interaction reference lists the prescription form, levocarnitine, with warfarin or acenocoumarol as usually not recommended [10].
  
  It allows the combination with dose adjustment where necessary [10]. ^[10]

Carnitine concentrates in animal foods, and red meat leads by a distance. Plant foods carry traces [1].

Per 3-ounce cooked serving: beef steak 42–122 mg, ground beef 65–74 mg, codfish 3–5 mg, chicken breast 2–4 mg [1].

Elsewhere: 1 cup whole milk 8 mg, ½ cup ice cream 3 mg, 2 oz cheddar 2 mg, 2 slices whole-wheat bread 0.2 mg, ½ cup cooked asparagus 0.1 mg [1].

Food carnitine absorbs at 63–75%, far better than supplemental L-carnitine's 14–18% [1].

For a 165-lb person, an omnivorous diet supplies about 24–145 mg/day; a vegan diet supplies about 1.2 mg/day [1].

That gap matters less than it looks. The same person synthesizes roughly 14.4 mg/day unaided, and strict vegetarians draw 90% or more of their carnitine pool from synthesis rather than food [1][7].

There is no established time-of-day guidance for carnitine, which follows from it not being an essential nutrient with a set intake schedule [1].

The one relevant pharmacokinetic fact: plasma L-carnitine peaks about 3.4 hours after a single oral dose, later than its shorter-acting ALC and PLC derivatives [3].

The specific rules you find online — empty stomach before training, between meals with coffee — come from commercial and practitioner blogs, not from trials [3]. We are leaving them off.